ArticleJournal of hepatocellular carcinoma2026

Efficacy of Lenvatinib versus Bevacizumab in Triple Therapy with Immune Checkpoint Inhibitors and Interventional Therapy for Hepatocellular Carcinoma with Macrovascular Invasion: A Multi-Center Real-World Retrospective Study.

Jiazhi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.